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Abstract
Background: Receptor tyrosine kinases (RTKs) participate in a multitude of signaling pathways, some of them via the small
G-protein Ras. An important component in the activation of Ras is Son of sevenless (SOS), which catalyzes the nucleotide
exchange on Ras.
Principal Findings: We can now demonstrate that the activation of Ras requires, in addition, the essential participation of
ezrin, radixin and/or moesin (ERM), a family of actin-binding proteins, and of actin. Disrupting either the interaction of the
ERM proteins with co-receptors, down-regulation of ERM proteins by siRNA, expression of dominant-negative mutants of
the ERM proteins or disruption of F-actin, abolishes growth factor-induced Ras activation. Ezrin/actin catalyzes the formation
of a multiprotein complex consisting of RTK, co-receptor, Grb2, SOS and Ras. We also identify binding sites for both Ras and
SOS on ezrin; mutations of these binding sites destroy the interactions and inhibit Ras activation. Finally, we show that the
formation of the ezrin-dependent complex is necessary to enhance the catalytic activity of SOS and thereby Ras activation.
Conclusions: Taking these findings together, we propose that the ERM proteins are novel scaffolds at the level of SOS
activity control, which is relevant for both normal Ras function and dysfunction known to occur in several human cancers.
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Introduction
The small G-protein Ras functions as a molecular switch
relaying extracellular stimuli to diverse intracellular effector
pathways, which are responsible for controlling proliferation,
motility and differentiation. Because of this central role Ras
activity and its downstream signaling pathways must be tightly
regulated. At the level of Ras the major determinants currently
known are guanine nucleotide exchange factors (GEFs), which
catalyze the loading of Ras with GTP replacing tightly bound
GDP, and GTPase-activating proteins (GAP), which down-
regulate the activity state by enhancing Ras-bound GTP
hydrolysis. Specificity of GEF activity e.g. Son of sevenless
(SOS) is linked not only to active RTKs through the adaptor
protein, Growth factor receptor-bound protein 2 (Grb2), but is
also influenced in its activity through interaction with membrane
lipids [1,2,3]. Further but less well understood complexity of the
Ras pathway has been created by the identification in the plasma
membrane of nanoclusters of proteins and lipids which are
thought to concentrate the components of effector cascades [4].
Also by the finding of scaffold proteins (e.g. kinase suppressor of
Ras, KSR, and sprouty-related proteins, (spred) thought to
coordinate kinetics of the downstream signaling components and
preventing activation of physiologically inappropriate signals
[5,6].
We discovered previously an additional level of regulation of the
Ras dependent MAP kinase pathway: Co-receptors specific for a
given RTK focus the MAP kinase activation to this receptor [7,8].
Our observations triggered our interest in defining at what level
this control was exerted. Most RTKs require co-receptors such as
integrins or other cellular adhesion molecules [7,8,9]. On the
extracellular side, one of the functions of co-receptors appears to
be the local enrichment or proper presentation of receptor ligands
[10,11]. On the intracellular side, the cytoplasmic domains of co-
receptors are required for RTK-dependent signaling [12,13,14].
Moreover, we identified a new component required for MAP
kinase activation – the filamentous actin (F-actin)-binding protein
ezrin (or other members of the ezrin-radixin-moesin (ERM)
family) that connects the actin cytoskeleton with the plasma
membrane. Initial evidence suggests that the ERM proteins bind
to the cytoplasmic domain of the co-receptor and from this
location required for growth factor induced Ras-MAP kinase
activation. However, the precise mechanism of their action has
remained elusive to date.
In the present study, we explore how the ERM proteins
precisely affect the MAP kinase pathway. We localize the step
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factor induced Ras activation is severely inhibited or even
abolished by either the disruption of the interaction of the ERM
proteins with co-receptors, by siRNA dependent down-regulation
of ERM proteins, by the expression of dominant-negative mutants
of ezrin, or by the disruption of F-actin. The actin-associated ezrin
carries independent binding sites for the co-receptor, for Ras and
for the autoinhibitory Dbl homology (DH) domain of the GEF Son
of sevenless (SOS), stabilizing a complex consisting of receptor, co-
receptor, Grb2, SOS, ezrin-actin and Ras. Mutations of these
binding sites destroy the interactions and inhibit the activation of
Ras. Furthermore, ezrin (used as an ERM protein prototype) not
only serves as a scaffold assembling the partners Ras and SOS, but
also appears to be an important regulator of SOS activity. Thus,
our data reveal a novel aspect of Ras signaling that may be
relevant to normal physiology as well as human cancer.
Results
Ezrin domains required for the catalysis of signal
transduction
We established the requirement of the ERM proteins for Ras
signaling by three independent methods and in several cell lines.
First, we overexpressed a soluble peptide – the cytoplasmic tail of
the co-receptor CD44 – that sequesters the ERM proteins
[10,15,16]. As a measure of Ras activity, we used Erk
phosphorylation. The wild type peptide, but not a mutant
defective in ERM protein binding (Figure S1A), strongly reduced
the basal and platelet-derived growth factor (PDGF)-induced
phosphorylation of Erk (Figure S1B). Kinetic resolution of PDGF
signaling revealed attenuated Erk activation characterized by a
shifted phosphorylation maximum (from 1 to 5 minutes) and lower
fold-induction (from 19 to 5 times; Figure S1C, D). Thus, removal
of the ERM proteins from the co-receptor interferes with
signaling.
Second, down-regulation of the ERM proteins by two
independent siRNA cocktails directed against all three ERM
proteins lowered PDGF-induced Erk phosphorylation, but did not
impair the activation of the PDGF receptor (PDGFR) itself
(Figure 1A; Figure S1E, F). As will be shown below, each of the
three ERM proteins contribute to activation of signaling, at least in
NIH3T3 cells (Figure 1F). Importantly, overexpression of all three
human ERM proteins or of ezrin alone rescued the mouse-siRNA-
dependent inhibition (Figure 1A). We conclude that the ERM
proteins are essential for PDGF signaling towards Erk.
Third, we interfered with ERM protein functions by mutations
in ezrin. Thereby, we also defined ezrin domains involved in Ras
activation. Ezrin mutants were overexpressed to compete with
endogenous ERM proteins for cellular interactions. We first
constructed ezrin with deletions in the C-terminus (Figure 1B;
Nterm and DABD deleting the actin-binding domain). These
mutant proteins are still able to bind to co-receptors at the plasma
membrane, but cannot interact with F-actin. Stable overexpres-
sion of these deletion mutants (as GFP fusions) abolished PDGF-
induced Erk phosphorylation (Figure 1C, left panel). Because the
deletions might abolish more than just the binding of ezrin to
actin, we used ezrin R579A (see Figure 1B), a mutant that is
completely defective in F-actin binding, but is otherwise
functionally intact [14]. Overexpression of this mutant, but not
of wild type ezrin, reduced PDGF-dependent and IL-6-dependent
Erk phosphorylation (Figure 1C, right panel; Figure S2A, B). Of
note, ezrin R579A was specific for Ras-dependent signaling in as
much as it did not interfere with PKC-induced Erk phosphory-
lation (Figure S2B) nor with IL-6-dependent STAT3 activation,
which is independent of Ras (Figure S2B). In conclusion, F-actin
binding or an unknown step linked to the ezrin/F-actin interaction
is crucial for PDGF signaling to Erk, possibly at the level of or
upstream of Ras.
Ezrin R579A prevents Ras activation
To address whether the mutants directly interfere with the
activation of Ras, we measured the PDGF-dependent loading of
GTP onto Ras. Overexpression of ezrin R579A (Figure 1C,D)
inhibited the activation of Ras. As a consequence of reduced Ras
activation, doxycycline-induced expression of ezrin R579A
inhibited agar colony formation of RT4 cells, which are driven
by mutated ErbB2 (Figure 1G). Interestingly, the effect of ezrin
was not limited to the signaling by the PDGFR, but was important
for other RTKs too. Epithelial growth factor (EGF)-induced Ras
activation was also abolished (Figure 1D), suggesting a general
requirement for the ERM proteins in RTK-induced Ras
activation. In addition, the contribution of the individual ERM
proteins to signal transduction was examined using the corre-
sponding mutants radixin R576A and moesin R570A. Overex-
pression of each mutant in NIH 3T3 cells inhibited spontaneous
and PDGF-induced Ras activation (Figure 1H). Specific siRNA
down-regulations (Figure 1F) showed that single knockdowns had
partial inhibitory effects on Ras activation, with the combination
of all three siRNAs being the most effective. Thus, all three ERM
proteins participate in catalyzing the signal transduction to Ras
and the overexpression of any one of the mutants competes with
the functions of all three wild type proteins.
Because ezrin R579A is defective in binding to F-actin, we
investigated whether actin itself has a role in Ras activation.
Latrunculin B, an inhibitor of actin polymerization (Spector et al,
1983), caused a reduction of stress fibers within minutes
(Figure 2A). It also inhibited PDGF-induced Ras activation and
downstream signaling to Erk (Figure 2B), while phosphorylation of
the receptor (Figure 2B) and its association with Grb2 (not shown)
were not affected. Interestingly, its effect on signaling was not
indiscriminate. While latrunculin B specifically interfered, in
addition to PDGF signaling, with the lysophosphatidic acid-
induced phosphorylation of CREB (Figure 2C) and of Erk (not
shown), and the IL-6-induced phosphorylation of Erk (Figure 2D),
it did not inhibit the activation of STAT3 in response to IL-6
(Figure 2D). Additionally, PKC-dependent Erk phosphorylation in
response to phorbol ester, which bypasses Ras, was not affected
(Figure 2E). Thus, despite the general disruption of the actin
cytoskeleton caused by this inhibitor (which is likely to be lethal
over a longer observation period), it exerts, at least at this early
time following growth factor stimulation, a very specific effect on
signal transduction through the Ras-Erk pathway.
Ezrin engages SOS and Ras
Because the actin-binding function of ezrin is required for Ras
activation, we speculated on the existence of an actin-associated
protein complex involving ezrin. Such a multiprotein complex was
indeed confirmed and its composition defined by immunoprecip-
itation. Optimal isolation of the complex including the PDGFR
was obtained using mild lysis conditions with Lubrol, a detergent
used for the solubilization of transmembrane protein complexes
[17,18,19]. Antibodies against the PDGFR co-precipitated both
the co-receptor b1-integrin and the ERM proteins following
PDGF stimulation (Figure 3A). In addition, the PDGF-activated
complex also contained Ras (Figure 3D), suggesting that SOS,
being a Ras regulator, may also be part of the complex. Indeed,
antibodies against SOS, as well as antibodies against the PDGFR,
precipitated the multiprotein complex including either endoge-
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results demonstrate that both SOS and Ras are part of the
complex. Ezrin R579A, however, could not be co-precipitated
with SOS or the PDGFR (Figure 3C,D), and, consequently,
expression of ezrin R579A blocked the formation of the PDGFR
complex.
Figure 2. Latrunculin B mimics the ezrin mutants. A Reduction in actin filaments by treatment with latrunculin B. The parental schwannoma
cells RT4 were plated at low density and treated with latrunculin B (1.25 mM, 10 min). Cells were processed as described in material and methods
(scale bar 10 mm). B Latrunculin B inhibits signaling. RT4 cells at low density were serum starved overnight, then treated with latrunculin B (1.25 mM,
5 min) prior to treatment with PDGF (10 ng/ml, 5 min). Lysates were treated with GST-Raf1-RBD (to pulldown Ras-GTP). Co-precipitated proteins were
immunoblotted with antibodies against Ras. Lysates immunoblotted as indicated. C, D, E Specific interference with signaling by latrunculin B. RT4
cells prepared and treated with latrunculin B as in panel A, then stimulated with LPA (20 mM, 5 min, panel B), IL-6 (1 ng/ml, 5 min, panel C) or TPA
(100 ng/ml, 5 min, panel D). Lysates immunoblotted as indicated. The results are representative of at least three independent assays and each panel
represents experiments from the same blot and the same exposure.
doi:10.1371/journal.pone.0027511.g002
Figure 1. ERM proteins are necessary for PDGFR signaling. A, Down-regulation of ERM proteins reduces PDGF-dependent Erk
phosphorylation. NIH 3T3 cells plated at low density were treated with a combination of siRNA SMARTpools against mouse ERM proteins for
24 hours. For exogenous reconstitution of human ERMs, cells were transfected with plasmid DNA coding for human ezrin-VSVg, radixin-Flag and
untagged moesin or ezrin-VSVg alone. Cells were serum starved overnight prior to treatment with PDGF for 5 min. Lysates were immunoblotted as
indicated. B, Schematic representation of the architecture of ezrin mutants. C, Ezrin mutants inhibit PDGF-dependent Erk phosphorylation. RT4 cells
at low density were transfected with either empty vector (control) or ezrin mutants (ezrinNterm-GFP or ezrin deleted in the Actin-Binding-Domain
ezrinDABD-GFP) (left panel) ezrin wild type or ezrin mutant R579A (right panel). Cells with high GFP expression were sorted by FACS, replated at low
cell density and serum starved overnight prior to induction with PDGF for 5 min. Lysates were immunoblotted as indicated. D, NIH 3T3 cells were
plated at a low density, co-transfected in a 5:1 ratio with constructs encoding either ezrin wild type-GFP or ezrin mutant-GFP and with a hygromycin
resistance construct, selected by hygromycin for 1 day, and serum starved overnight prior to treatment with PDGF or EGF for 3 min. For Ras-GTP
levels, lysates were treated with GST-Raf1-RBD (Ras-binding domain, RBD). Co-precipitated proteins were immunoblotted with antibodies against Ras.
Lysates were immunoblotted as indicated. E, Ezrin R579A also inhibits PDGF-dependent Ras activation in RT4 cells. Experiment as in D, except ezrin
constructs encoding either ezrin wild type-VSVg or ezrin mutant-VSVg were used. F, Down-regulation of individual ERM proteins using a cocktail of
specific siRNAs reduces PDGF-dependent Ras activation in NIH 3T3 cells. Ras activity was determined as in D. G, Ezrin mutant, but not wild type ezrin,
inhibits agar colony formation in RT4 cells. Dox-inducible ezrin wild type- or mutant-expressing cells were generated and placed in soft agar (2 and +
dox). Results represent mean absolute colony number 6 s.d. of at least three independent experiments, **P,0.01 using student’s t-test. H, The F-
actin-binding mutants of moesin (R570A, middle panel) and radixin (R576A, right panel) inhibit PDGF-dependent Ras activation in NIH 3T3 cells.
Experiment set up as in D. In all panels lysates immunoblotted as indicated. The results are representative of at least three independent assays and
each panel represents experiments from the same blot and the same exposure.
doi:10.1371/journal.pone.0027511.g001
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activation
Because the association of Ras with SOS should be transient and
not stable enough for immunoprecipitation, the co-immunoprecip-
itationdata might indicatethat ezrin forms a stabilizingscaffold that
assembles Ras and SOS. Employing three independent techniques,
we provide evidence for a direct interaction between Ras and ezrin
(Figure 4). First, a fusion protein of the N-terminus of ezrin and
GST, but not GST alone, brought down Ras from cell lysates
(Figure 4A). Furthermore, a fusion protein of GST and Ras
precipitated the purified N-terminus of ezrin, but not the C-
terminus (Figure 4B). Finally, purified His-tagged ezrin precipitated
purified Ras (Figure 4C).
Second, if the interaction of ezrin and Ras serves to stabilize the
complex with SOS prior to nucleotide exchange, then Ras-GDP
should be the preferred interaction partner of ezrin. Indeed, it was
Ras-GDP that was pulled down with His-tagged ezrin (Figure 4C).
Another technique using Ras loaded with fluorescent-labeled GDP
(mantGDP-Ras) also demonstrated interaction. The fluorescence
intensity increased in a concentration-dependent manner when
ezrin was added to mantGDP-Ras (Figure 4D), indicating that Ras-
GDP and ezrin do indeed interact.
Finally, ezrin carries a motif in its N-terminal domain which
resembles the Ras-binding domain of Raf1 kinase [20]. To test
whether this motif is involved in the ezrin-Ras interaction, we
mutated several amino acids individually within this motif [21,22].
Of these mutants, ezrin R40L lost the ability to bind Ras most
strongly (Figure 4E). Expression of ezrin R40L abolished PDGF-
induced activation of Ras (Figure 4F) and inhibited serum-
dependent incorporation of BrdU (Figure 4G). Therefore, the
most straightforward explanation of these findings is that Ras and
ezrin interact directly and that this interaction is part of the
scaffolding function of ezrin required for Ras activation.
Ezrin interacts with the Dbl homology (DH)-pleckstrin
homology (PH) domains of SOS
The ezrin mutants identify ezrin as an organizer of both SOS
and Ras. The ability of ezrin to act as a scaffold for SOS was
further suggested from mapping the domains of SOS interacting
with ezrin (SOS constructs are illustrated and described in
Figure 5A). Co-immuno and co-affinity precipitation experiments
identified the DH-PH tandem domains as an interaction site for
ezrin (Figure 5B,C). As suggested from the co-IP experiments of
Figure 3 and ezrin mutant R579A lacking binding to actin,
Figure 3. Ezrin engages in a complex with SOS and Ras. A, Endogenous ERM proteins associate with the PDGFR and its co-receptor b1-
integrin. RT4 cells were plated at low density, serum starved overnight and treated with PDGF for 1 min. Proteins co-immunoprecipitated (CoIP) with
PDGFR were immunoblotted, rabbit lgG was used for control IP. B, Endogenous ERM proteins associate with SOS and Ras. RT4 cells treated as in A.
SOS was immunoprecipitated by a rabbit SOS-specific antibody, rabbit lgG was used for control IP. Coimmunoprecipitated proteins were
immunoblotted. C, Ezrin R579A cannot associate with SOS and Ras. RT4 cells expressing dox-inducible ezrin wild type or R579A mutant were plated
at low density, serum starved overnight and incubated with dox prior to treatment PDGF for 1 min. Proteins co-immunoprecipitated with SOS (as in
B) were immunoblotted as indicated. D, Ezrin R579A cannot associate with the PDGFR and Ras. Cells were treated as in C followed by PDGFR-CoIP (as
in A). Proteins co-immunoprecipitated with PDGFR were immunoblotted as indicated. The results are representative of at least three independent
assays and each panel represents experiments from the same blot and the same exposure.
doi:10.1371/journal.pone.0027511.g003
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with SOS (full length) and F-actin, not G-actin (Figure 5D). Wild
type ezrin engaged SOS (full length) only in the presence of F-
actin, the mutant defective in F-actin binding (R579A) did not
(pulldown with His-tagged ezrin). Thus, interestingly, ezrin in
conjunction with F-actin appears to adopt a specific SOS-binding
conformation, enabling the interaction with the DH/PH domain
of SOS.
Ezrin interaction with the allosteric site of SOS enhances
SOS activity
The GEF SOS is itself subject to complex regulation. The DH-
PH domains decrease catalytic activity by folding back onto the
catalytic domain and restricting the accessibility to a second Ras-
binding site distal to the catalytic one. This allosteric Ras-binding
site is absolutely required for the full activation of SOS,
implicating Ras itself as an essential determinant of SOS
regulation [23]. While we identified ezrin as a scaffold protein
assembling for both Ras and SOS, we considered whether ezrin
might, in addition, help to activate SOS, perhaps by removing this
steric block and presenting Ras-GDP to the allosteric site on SOS,
essential for SOS activity [23]. This interesting possibility
encouraged us to measure cellular SOS activity in the presence
or absence of ezrin. Furthermore, in vitro experiments comparing
SOS with SOS in complex with ezrin were subsequently
performed.
First, we tested whether ezrin is required for SOS nucleotide
exchange activity in vivo by following the uptake of [a
32P]-GTP
Figure 4. Ezrin interacts directly with Ras. A, EzrinNterm interacts with Ras. RT4 cell lysates were incubated with GST-Nterminal ezrin or GST
alone. GST pull-downs were immunoblotted as indicated. B, Direct interaction between Ras and ezrin determined by GST pull-down. Purified GST-Ras
or GST agarose alone was incubated with purified recombinant N-terminal or C-terminal half of ezrin. The pull-down was subjected to SDS-PAGE,
followed by colloidal Coomassie staining. C, Ezrin binds to GDP-loaded Ras. Recombinant Ras loaded with GDP or non-hydrolysable GTPcS was
incubated with His-ezrin wild type. The His pull-down was immunoblotted as indicated. D, Ezrin binds fluorescent GDP-Ras in solution. Bacterially
expressed Ras was loaded with fluorescent mantGDP. 1 mM mantGDP-Ras was then incubated with increasing amounts of recombinant ezrin wild
type and fluorescence intensity was measured. E, Ezrin R40L cannot bind Ras. NIH 3T3 lysates of cells expressing dox-inducible ezrin wild type-VSVg
or ezrin R40L-VSVg were incubated with GDP- or GTPcS-loaded GST-Ras agarose or GST agarose alone (control). The GST pull-down was
immunoblotted as indicated. F, Ezrin R40L inhibits PDGF-dependent Ras activation. NIH 3T3 cells expressing dox-inducible ezrin wild type or R40L
mutant were plated at a low density, serum starved overnight prior to treatment with PDGF for 3 min. Ras activity was determined as in 1D. Lysates
were immunoblotted as indicated. G, Ezrin R40L, but not wild type ezrin, inhibits BrdU incorporation as quantified with a fluorescein-coupled BrdU
antibody. Dox-inducible ezrin wild type- or mutant-expressing NIH 3T3 cells were generated and placed in soft agar (2 and + dox). Quantitative
results represent mean 6 s.d. of at least three independent experiments, **P,0.01 using student’s t-test. The results are representative of at least
three independent assays and each panel represents experiments from the same blot and the same exposure.
doi:10.1371/journal.pone.0027511.g004
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32P]-GTP onto Ras. The
nucleotide exchange activity in resting cells was high; however, it
was insensitive to ERM protein knockdown and also to the
expression of ezrin mutants R579A or R40L, indicating that basal
SOS activity does not depend on ERM proteins (Figure 6A–C). At
present, we do not have an explanation for this high SOS activity
in resting cells, which has also been reported by another group
[24]. In marked contrast to the basal SOS activity, the PDGF-
sparked acceleration of nucleotide uptake onto Ras was completely
abrogated by ERM protein knockdown and also by the expression
of ezrin R579A or R40L (Figure 6A–C). The disrupting effect of
these ezrin mutants reflects an essential contribution of the ezrin/
F-actin and ezrin-Ras complexes to the growth factor-dependent
enhancement of SOS activity. We conclude that the ERM
proteins are targeted to the plasma membrane/F-actin interface
where they assemble SOS and Ras. This action possibly
contributes to the release of SOS autoinhibition, thus enabling
the presentation of Ras to the allosteric regulatory site of SOS.
Ezrin controls SOS activity in vitro
Based on these in vivo data, we investigated the effect of ezrin
on SOS activity in vitro using precipitated complexes. PDGF-
induced protein complexes were collected by GST-Grb2 pull-
downs (the stoichiometric interaction of Grb2 with SOS
ascertained equal SOS levels) of total lysates of cells expressing
wild type or R579A ezrin. The complexes were incubated with
recombinant Ras preloaded with radioactive GTP; the exchange
reaction was initiated by adding an excess of non-radioactive
GTPcS. Despite the presence of equal amounts of SOS
(Figure 6D, right panel), a much higher exchange activity was
observed in samples containing the SOS-ezrin wild type complex
compared with the complexes precipitated from ezrin R579A-
expressing cells (Figure 6D). These latter precipitates contained
no ezrin (Figure 6D, right panel). This in vitro experiment
demonstrates that SOS exerted significant nucleotide exchange
activity only when bound to wild type ezrin.
Discussion
We show here that the activation of Ras is linked to actin
dynamics and the presence of the ERM proteins. The classic
model for the regulation of Ras by the GEF SOS involves the local
assembly of SOS through adaptor proteins upon ligand stimula-
tion of a RTK. One of these adaptor proteins, Grb2, brings SOS
into proximity with the receptor where it is thought to engage Ras.
However, we can now demonstrate a novel step in the control of
Ras where regulators of the plasma membrane-cytoskeleton
interphase, the ERM proteins, are essential for Ras activation
downstream of RTK activity. We show that the ERM proteins in
conjunction with F-actin associate with co-receptors, such as b1-
integrin, focusing the ERM proteins to relevant sites of RTK
activity with which the co-receptors are linked. Our observation
that disruption of the interaction of the ERM proteins with co-
receptors (by sequestering, by siRNA down-regulation or expres-
sion of dominant-negative mutants of the ERM proteins) abolishes
Figure 5. Ezrin interacts with the DH-PH domains of SOS. A, Schematic representation of the architecture of used SOS constructs. B, ERM
proteins interact with the DH-PH domains of SOS. Incubation of His-SOS DH-PHcat- or His-SOScat with RT4 lysates. His pull-downs were
immunoblotted as indicated. C, ERM proteins interact with the DH-PH domain of SOS. NIH 3T3 cells were transfected with constructs expressing Myc-
tagged fragments of SOS (specific band marked with a red asterisk) or an empty vector control. Co-precipitated proteins were immunoblotted with
antibodies against the ERM proteins. D, Full-length SOS interacts with ezrin in vitro only in the presence of F-actin. SOS was incubated with ezrin wild
type- or R579A-His in the presence of filamentous (F) or globular (G) actin. The His pulldown was immunoblotted as indicated. The results are
representative of at least three independent assays and each panel represents experiments from the same blot and the same exposure.
doi:10.1371/journal.pone.0027511.g005
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the ERM proteins in the control of Ras.
In response to the growth factor PDGF we could show that the
ERM/actin catalyze the formation of a multiprotein complex
consisting of RTK, co-receptor, Grb2, SOS and Ras. In addition
we identify ezrin and possibly other ERM proteins as new
intracellular scaffold partners for Ras and SOS. Ezrin directly
assembles Ras and SOS via separate domains of ezrin, and ezrin
mutants unable to interact with Ras or SOS severely compromise
Ras activity induced by PDGF or EGF. Moreover the PDGF-
induced stimulation of guanine nucleotide uptake by Ras in
permeated cells is specifically aborted by siRNA down-regulation
of the ERM proteins or expression of dominant-negative ezrin
mutants. These data suggest that functional ezrin directly
assembling Ras and SOS is required for the PDGF-dependent
stimulation of nucleotide exchange on Ras.
Beyond scaffolding function ezrin could be a new intracellular
partner required for SOS regulation. SOS, like other GEFs, is a
large protein with autoinhibitory domains. According to mutant
data [23], SOS requires to be unfolded in order to enable the
access of Ras to an allosteric regulatory site which then releases the
catalytic activity. The catalytic domain then promotes the
exchange of GTP for GDP on another Ras molecule. An in vitro
Ras activation assay performed with purified SOS isolated from
cells demonstrated that its GEF activity is enhanced only when
associated with ezrin. We propose that ezrin not only assembles
Figure 6. ERM proteins influence full-length SOS GEF activity towards Ras. A, In vivo GEF activity is associated with presence of ERM
proteins. NIH 3T3 cells were treated with siERM cocktail, followed by permeation with streptolysin O in the presence of [a
32P]-GTP and PDGF
treatment. Bound [a
32P]-GTP caught in the binding pocket of immunoprecipitated Ras was measured. B In vivo GEF activity is associated with wild
type but not R579A ezrin. Dox treatment of dox-inducible ezrin wild type (ezrinWT) or R579A (ezrinRA) NIH 3T3 cells, followed by in vivo GEF activity
measurement as described in C. C, In vivo GEF activity is associated with wild type but not R40L ezrin indicating that GEF activity is dependent on Ras
binding of ezrin. Dox treatment of dox-inducible ezrin wild type (ezrinWT) or R40L (ezrinRL) NIH 3T3 cells, followed by in vivo GEF activity
measurement as described in C. Results represent mean 6 s.d. of at least 3 independent experiments. ONEway ANOVA statistical analysis was
performed. D, SOS/wild type ezrin complex has high in vitro GEF activity. (Left panel) SOS/ezrin complexes incubated with Ras preloaded with [a
32P]-
GTP. The reaction was initiated with excess GTPcS and the loss of Ras-bound radioactive GTP measured. Quantitative results represent mean 6 s.d. of
at least 3 independent experiments, **P,0.01 using student’s t-test. (Right panel) Immunoblot shows equal amounts of SOS precipitated from ezrin
wild type- and R579A-expressing cells. The results are representative of at least three independent assays and each panel represents experiments
from the same blot and the same exposure.
doi:10.1371/journal.pone.0027511.g006
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the autoinhibitory DH-PH domains of SOS possibly contributing
to the release of SOS autoinhibition and/or presenting Ras to the
allosteric regulatory site of SOS (a model illustrating the proposed
mechanism of SOS activation is shown in Figure 7).
While this study presents evidence that ezrin is required for the
activation of SOS; we should however, consider that other
partners are required for the full activation of SOS. A likely
candidate is the plasma membrane due to its proximity. Indeed,
our in vitro GEF assay with isolated SOS contained lipids in
addition to ezrin. Lipid interaction has previously been shown to
release SOS autoinhibition. For example, binding of phosphoino-
sitides to the PH domain [1] as well as binding of phosphatidic
acid to the histone-like domain of SOS are important modulators
of its autoinhibition [2,25,26]. Taking these findings together, the
in vivo targeting of ezrin to the plasma membrane and its direct
interaction with SOS are both essential features for the full
activation of SOS (see proposed model, Figure 7). It is noteworthy
to mention that these principles of ezrin-mediated activation of
SOS may have a more widespread significance. As several other
GEFs also require release from autoinhibition, ezrin might also
promote the activation of these GEFs. Indeed, binding of GEFs
other than SOS, such as Dbl and Dock180, to ERM proteins has
been reported by several laboratories [27,28,29]. However, these
groups did not address the mechanism of action.
Another feature of ezrin that is required for the activation of
Ras is the binding of F-actin. This is demonstrated by the
dominant-negative effect of ezrin R579A (which eliminates the
binding of F-actin whilst retaining the association with membrane
proteins) and by the similar effect of an actin polymerization
inhibitor. The most straightforward explanation of these findings is
that F-actin is part of a stabilizing complex, which specifically
focuses the ERM proteins to RTKs at the plasma membrane.
However, our in vitro data showing that ezrin can only interact with
SOS in the presence of F-actin imply more than a scaffold
function: ezrin might adopt a specific SOS-activating conforma-
tion only when associated with F-actin. While our findings suggest
a role for the ezrin-actin link in signaling, another interesting but
different function of actin in signaling relates to the activation of
the transcription factor SRF. The abundance of free G-actin
inhibits SRF activity by retaining one of its co-activators, MAL, in
the cytoplasm [30]. Signaling pathways inhibiting F-actin
depolymerization or promoting filament assembly co-operate in
preventing the activation of the SRF/MAL complex – this
complex addresses a subset of SRF target genes, e.g. the actin
promoter itself [31]. Another subset requiring the interaction of
SRF and the co-activator TCF is addressed by Erk [32] and is
likely to be dependent on the signal-promoting effect of cortical F-
actin presented here.
The coupling of co-receptors to ezrin/F-actin could be regarded
as a platform to co-ordinate and restrict the encounter of SOS
with Ras, thereby fine-tuning growth factor signals. The control of
Ras activity is critical and can falter by mutation at several levels,
e.g. oncogenic mutations of Ras [33] or an inactivating mutation
of the gene NF1 encoding neurofibromin [34]. In addition,
dysregulation of RTKs is often the cause of the development and
maintenance of cancer [35]. It is of no surprise that the
components of the RTK-dependent signaling steps identified
Figure 7. Model of ezrin-mediated activation of SOS. Growth factor (GF) induction promotes ezrin activation, which localizes to co-receptors/
adhesion receptors, while SOS couples to the activated RTK. Ezrin in conjunction with F-actin binds to the DH-PH domains of SOS, creating a stable
anchorage to the membrane and assisting the release of SOS autoinhibition. With the unmasking of the distal/allosteric site (unmasked site now
illustrated by yellow star; masked conformation in grey), ezrin binding to Ras-GDP increases the ability of Ras-GDP to engage this allosteric site,
promoting the ability of SOS to catalyze nucleotide exchange (GDP illustrated by two and GTP by three red balls).
doi:10.1371/journal.pone.0027511.g007
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overexpressed in cancer [7,36,37,38]. Thus, our proposed model
of ezrin-mediated activation of SOS now allows us to conceive
how such inappropriate activation of co-receptors, e.g. mis-
expression of the co-receptor CD44v6 for the RTK c-Met [39],
as well as elevated expression of ezrin [37], radixin [38] and
moesin [36] may contribute to cancer progression and metastasis.
Methods
Growth factors, antibodies and reagents
Recombinant human platelet-derived growth factor BB (PDGF)
(Biomol); recombinant human interleukin-6 (IL-6), epidermal
growth factor (EGF), lysophosphatidic acid (LPA), 12-o-tetrade-
canoyl-phorbol-13-acetate (TPA), Igepal CA-630, Triton-X-100,
GDP, GTPcS and doxycycline (dox; Sigma); mantGDP,
mantGTP and GST protein (Jena Bioscience); Lubrol 17A17
(Uniqema); ATP (Roche); GST-Grb2 glutathione agarose (GST-
Grb2), Raf1-Ras-binding domain glutathione agarose (GST-Raf1-
RBD), GST-Ras- and GST-agarose (Upstate); latrunculin B
(Calbiochem); glutathione agarose (Santa Cruz). Antibodies:
GST (B-14), Integrin-b1 (M-106), Erk1 (K23), Ezrin (C-19),
moesin (C-15), radixin (C-15), Actin (I-19), SOS1 (C-23), PDGFR-
b (958), GFP (B-2), Myc (9E10), Tubulin (TU-02) (Santa Cruz);
Ras (RAS10) (Upstate); VSVg, HA (Roche); Flag (F1804) (Sigma);
ezrin (3C12) (NeoMarkers); against phosphorylated proteins:
PDGFR-b (Y716) (Upstate); Erk (Thr202/Tyr204), Stat3
(Tyr705), CREB (Ser133), ezrin(Thr567)/radixin(Thr564)/moesin
(Thr558) (Cell Signalling).
Plasmids
EzrinWT-, N- and Cterminal-GFP, and ezrin(DABD)-EGFP-
N1 (Antonio Sechi, Braunschweig). EzrinWT- and T567D-VSVg
(pCB6), ezrin N- and Cterminal-GST, Human ezrinWT- and
T567D-Myc in pcDNA3.1 (Monique Arpin, Paris). EzrinWT- and
T567D-VSVg fragments were subcloned into pUHD10.3 rtTA-
responsive cloning vector (EcoR1/Xba1). Ezrin Nterm- and
Cterm-GST were cloned into pGEX4T-1 vector (BamH1/
EcoR1). Human moesinWT (Dominique Lallemand, Paris)
expression construct was generated in pcDNA3.1 (Kpn1/Not1),
and a dox-inducible radixinWT-Flag (pcDNA3 Human radix-
inWT-Flag, David Gutmann, St. Louis, Washington) was created
in pUHD10.3 (BamH1/EcoR1). Myc-SOS and His-SOScat
constructs were generated by PCR, then cloned into the
pcDNA3.1/V5-His-TOPO vector (Invitrogen). GST-CD44tail
and GST-CD44tail mutant in pEBG-GST were generated as
described in Morrison et al., 2001. Myc-H-Raps and HA-RasWT
in pcDNA3.1 (UMR cDNA Resource Center, University of
Missouri-Rolla, USA). For protein purification, ezrinWT-His was
cloned in pET15TEV expression vector (C. Breithaupt-Than,
Halle). His-SOScat (aa 564–1094) in pProEX HTb expression
vector was obtained from A. Wittinghofer, Dortmund. His-SOS
DH-PHcat (aa 198–1049), His-SOS HDPcat (aa 1–1049) and His-
H-Ras (aa 1–166) were cloned in pET15TEV expression vector
(BamH1). All point mutations were generated using a site-directed
mutagenesis kit (Stratagene).
siRNA experiments
The down-regulation of ERM proteins was carried out using
short interfering RNA (siRNA) according to the procedure
described in [40]. Single siRNA oligonucleotides were purchased
from Ambion (only the sense strand is reported): ezrin (rat, Set I):
59-UCAACUAUUUCGAGAUCAAAA-39 (ORF 606–629), ezrin
(rat, Set II): 59-GGGACUCAGGCCUGUUUAUtt-39 (ORF
2710–2732); radixin (rat, Set I): 59-CUCGUCUGAGAAU-
CAAUAAGC-39 (ORF 752–775), radixin (rat, Set II): 59-
GCUGUGGCUGGGCGUUGAUtt-39 (ORF 852–874); moesin
(rat, Set I): 59-GGCUGAAACUCAAUAAGAAGG-39 (ORF
171–194), moesin (rat, Set II): 59-GGCCCUGCUGCAGGCUU-
CUtt-39 (ORF 1299–1321); ezrin (mouse, Set I): 59-GCCGUAU-
GUAGACAAUAAAGG-39 (ORF 139–161), ezrin (mouse, Set II):
59-GGCCAAGUUCGGAGAUUAUtt-39 (ORF 528–550); ra-
dixin (mouse, Set I): 59-GCACCUCGUCUGAGAAUCAAU-39
(ORF 809–822), radixin (mouse, Set II): 59-GCUGUGGCUAG-
GUGUUGAUtt-39 (ORF 1195–1217); moesin (mouse, Set I): 59-
GCAAGCCUGACACCAUUGAGG-39 (ORF 882–905), moesin
(mouse, Set II): 59-GGCCCUGCUGCAGGCUUCUtt-39 (ORF
1388–1410); Control (Ctr) siRNA (against firefly luciferase) 59-
CGUACGCGGAAUACUUCGA-39. SMART pools (cocktail of
four siRNAs) against ezrin (mouse), moesin (mouse) and radixin
(mouse) were purchased from Dharmacon (sequences will be
provided upon request). The down-regulation of ERM proteins in
HeLa and RPM-MC was carried out the following siRNA
duplexes: ezrin (human, Set I): 59-CCCCAAAGAUUGG-
CUUUCC-39 (ORF 704–722), ezrin (human, Set II); 59-
UCCACUAUGUGGAUAAUAA-39 (ORF 140–158); moesin
(human, Set I): 59-AAAAGCCCCGGACUUCGUC-39 (ORF
786–804), moesin (human, Set II): 59-AGAUCGAGGAACAGA-
CUAA-39 (ORF 1058–1076); radixin (human, Set I): 59-GCA-
GUUGGAAAGGGCACAA-39 (ORF 948–966), radixin (human,
Set II): 59-CUCGUCUGAGAAUCAAUAA-39 (ORF 752–775).
As control, the following scrambled duplexes (derived from Set I
duplexes) were used: ezrin 59-CCGUCACAUCAAUUGCCGU-
39, moesin 59-ACUAGACGAACCGUCGCUC-39, radixin 59-
GAUGCAGCAGCAUGAAGAG-39.
Cell culture
RT4-D6P2T (RT4) rat schwannoma cell line ENU-induced
RT4-D6P2T rat schwannoma cell line (mutated ErbB2 activates
the Ras-MAP kinase cascade) [41], NIH 3T3 mouse fibroblasts
and HeLa human cervix epitheloid carcinoma cell line (European
Collection of Animal Cell Cultures). RT4 and NIH 3T3 cells
carrying doxycycline (dox)-inducible ezrin wild type or ezrin
mutants (named either RT4tetEzrin or NIH 3T3tetEzrin) were
prepared as described in Morrison et al., 2001. Cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM; Gibco-BRL)
supplemented with 10% foetal calf serum (FCS; Gibco-BRL) or
10% donor calf serum (Gibco-BRL) for NIH 3T3. All cells were
maintained in a humidified atmosphere with 5% CO2 at 37uC.
The concentration of dox in all cell culture experiments was
1 mg/ml.
Stable and transient transfection of cells
Transfections (both RNAi and plasmid DNA) were performed
using Lipofectamine (Invitrogen), in accordance with the manu-
facturer’s instructions. To generate stable or pooled clones, cells
were co-transfected with pCEP4 (hygromycin resistance) (Invitro-
gen), and selected in 100 mg/ml hygromycin (Roche). Note, dox-
inducible ezrin wild type or ezrin mutants as well as ezrin
expressing stable/pooled clones over-expressed exogenous ezrin
more than 35 times compared to endogenous ezrin levels.
Definition of growth condition in culture dishes
Low cell density (=logarithmic or exponential growth) was
defined as the density recorded at 24 h after seeding 500 cells per
cm
2. High cell density (=confluent growth condition) was defined
as the density recorded at 24 h after seeding 5610
3 cells per cm
2
(1610
5 cells per cm
2 for NIH 3T3).
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Cells were grown on coverslips placed in six-well plates. Cells
were fixed with 4% paraformaldehyde in ‘‘cytoskeleton buffer’’
(CB: 10 mM PIPES, 150 mM NaCl, 5 mM EGTA, 5 mM
glucose, 5 mM MgCl2, pH 7.0) at room temperature for
20 min, washed 3 times in CB and permeated in 0.05% Triton-
X-100 in PBS for 1 min. Actin fibers were detected by phalloidin
conjugated to Alexa 594 (Molecular Probes) for 1 hour at a
dilution of 1:50. Cells were washed 3 times, mounted on glass
slides with 10 ml Prolong Antifade reagent (Molecular Probes) and
images obtained using epifluorescence with an Axiovert 135 TV
microscope (Zeiss) equipped with a Plan-Apochromat 1006/1.40
NA oil immersion objective. Images were recorded with a cooled,
back-illuminated CCD camera (TE/CCD-1000 TKB, Princeton
Instruments) driven by IPLab Spectrum software (Scanalytics).
GEF activity measurement – streptolysin O
Intracellular GEF activity was measured as described in de
Vries-Smits et al., 1995 and Stephens et al., 1993. In brief, NIH
3T3 cells were seeded in 6-well plates at 6610
3 cells/cm
2.
Transfection of siRNA duplexes or DNA constructs expressing
ezrinWT, R579A was performed the next day (the R40L a dox
inducible mutant cell line was used). Another day later, cells were
deprived of serum overnight to perform the assay after 48 h of
ERM knock-down or construct expression (dox added were
indicated). Assay kinetics was started after culture medium was
replaced with 600 ml permeation buffer (50 mM HEPES pH 7.5,
107 mM K-glutamate, 23 mM NaCl, 3 mM MgCl2, 0.3 mM
CaCl2, 1 mM EGTA, 1 mM ATP, 30 U/ml streptolysin O (Aalto
Bioreagents), 100 mCi/ml [a
32P]-GTP (Hartmann Analytik) and
2/+ 10 ng/ml PDGF). At indicated time points, the exchange
reaction was stopped by adding 1 ml lysis buffer (50 mM HEPES
pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1% NP-40, 100 mM
GDP, 100 mM GTPcS, protease inhibitor cocktail ‘complete w/o
EDTA’ (Roche) and 5 mg/ml anti-Ras antibody Y13-259). Lysates
were cleared by centrifugation, supplemented to contain 500 mM
NaCl, 0.6% sodium deoxycholate and 0.06% SDS, and Ras was
immunoprecipitated with protein Gplus agarose (Oncogene). The
precipitates were washed six times with 1 ml Ras wash buffer
(50 mM HEPES pH 7.5, 500 mM NaCl, 5 mM MgCl2, 0.1%
Triton-X-100 and 0.005% SDS) and subjected to Cherenkov
counting.
GEF activity measurement – SOS containing complexes
from cells
Measurement of nucleotide exchange activity of SOS towards
Ras was performed as described in Downward et al., 1995 and
Rubio et al., 1999. In brief, four 15 cm plates were used. In each
plate 2610
6 dox inducible NIH 3T3 cells were seeded (dox
inducible for ezrinWT or ezrinR579A mutant). The next day cells
were serum starved and dox added overnight. Following day, in
each plate cells were lysed in 1 ml lysis buffer after 10 ng/ml
PDGF stimulation (50 mM HEPES pH 7.4, 0.5% Lubrol 17A17,
100 mM NaCl, 5 mM sodium vanadate, and protease inhibitor
cocktail ‘complete w/o EDTA’). The lysate was mixed and then
divided again into four and SOS was pulled down for 2 h using
GST-Grb2. Equal amount of SOS and the presence of ezrin were
confirmed by immunoblotting. The pulldowns were stored on ice
until used in the exchange assay. Ras loading: Recombinant H-
Ras (50 ng) was loaded at 37uC for 5 min with 25 mCi [a
32P]-
GTP in 100 ml loading buffer (50 mM HEPES pH 7.5, 5 mM
EDTA and 5 mg/ml BSA). The reaction was stopped by adding
5 ml 0.5 M MgCl2 on ice. High-magnesium buffer (800 ml)
(50 mM HEPES pH 7.5 and 5 mM MgCl2) and 1 mM cold,
non-radioactive GTP were added, and MgCl2 was adjusted to
5 mM. This mixture (25 ml) was added to the immunoprecipitates
and nucleotide exchange was assayed at 30uC for 30 min. The
reaction was stopped by placing on ice and adding 300 ml Ras
wash buffer, 1 mg/ml BSA and 5 mg Y13-259 anti-Ras antibody.
Ras was immuno-precipitated with protein Gplus agarose. The
precipitates were washed four times with 1 ml Ras wash buffer and
subjected to Cherenkov counting.
Protein purification from Escherichia coli
The expression vector pET15TEV fuses an N-terminal
polyhistidine tag to the protein followed by a tobacco etch virus
(TEV) cleavage site. E. coli cells (Rosetta 2 DE3, Novagen) were
transformed with SOS, ezrin or Ras protein expression constructs
and grown in LB medium supplemented with antibiotics (100 mg/
l ampicillin and 100 mg/l chloramphenicol; Carl Roth). Protein
expression was induced by 100 mM IPTG (for Ras; Carl Roth),
250 mM IPTG (SOS) or 500 mM IPTG (ezrin) at a cell density
corresponding to an absorbance of 0.4–0.6 at 600 nm, and the
proteins were expressed at 33uC overnight (Ras), at 30uC for 6 h
(SOS) or at 37uC for 4 h (ezrin). Cells were collected by
centrifugation for 20 min at 6,0006g, resuspended in either Ras
resuspension buffer (RB; 25 mM Tris pH 7.4, 2.5 mM MgCl2,
100 mM GDP and 0.5% Triton-X-100), SOS resuspension buffer
(50 mM Tris pH 7.4, 1 M NaCl and 0.5% Triton-X-100) or ezrin
resuspension buffer (50 mM Tris pH 8.0 and 150 mM NaCl)
containing protease inhibitors and snap frozen in liquid nitrogen.
After thawing, lysozyme (Carl Roth) was added. Cell lysis was
carried out by ultrasonification (15 sec impulse, 30-sec break). Cell
debris was collected by centrifugation at 15,0006g in a JA 25.50
rotor for 10 min. All purifications were carried out at 4uC. The
remaining clear lysate was incubated with Ni-Sepharose 6 Fast
Flow (GE Healthcare) overnight and transferred to Glass Econo-
Column Columns (Bio-Rad). After several washing steps with RB
and RB plus 30 mM imidazole, proteins were eluted using
250 mM imidazole in the corresponding RB (including 140 mM
NaCl for Ras). Fractions containing proteins were pooled and
dialyzed against buffer: Ras (50 mM Tris pH 7.4, 5 mM MgCl2
and 1 mM DTT); SOS (20 mM Tris pH 8.0 and 100 mM NaCl);
and ezrin (50 mM Tris pH 8.0 and 150 mM NaCl). SOS and Ras
proteins were aliquoted, snapped frozen and stored at 280uC.
Ezrin proteins were either kept at 4uCo r220uC. When required,
the His-tag was cleaved using TEV Protease (Promega) following
the manufacturer’s instructions.
Protein purification from insect cells
Full-length SOS1 was prepared essentially as described in [42].
Briefly, Sf9 cells (Merck, Biosciences, Germany) infected in triple-
bottom culture flasks with a baculovirus encoding the sequence of
full-length human SOS1 in fusion with an N-terminal Glu-Glu
epitope tag (EYMPME) (cloned in transfer vector pAcC13, kind
gift of Frank McCormick, San Francisco) were harvested 72 h post
infection. Cells were washed once in PBS, resuspended in 10 ml
ice-cold hypotonic solution (50 mM Tris pH 7.5, 5 mM MgCl2,
1 mM DTT and protease inhibitors)/ml cell pellet and placed on
ice for 10 min. Cells were lysed with 20 strokes in a Dounce
homogenizer on ice and insoluble debris was removed by
centrifugation at 100,0006g for 30 min at 4uC. The supernatant
was loaded onto a 1–2-ml anti-Glu-Glu column pre-equilibrated in
buffer A (50 mM Tris pH 7.5, 150 mM NaCl, 5 mM MgCl2,
1 mM DTT and protease inhibitors), previously prepared by
coupling 1 mg anti-Glu-Glu antibody (kind gift of Julian
Downward, London) to 1 ml Actigel matrix (Sterogene) following
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washed with 10 ml buffer A, 10 ml buffer A supplemented with
0.5% NP-40, 10 ml buffer A supplemented with 500 mM NaCl
and 10 ml buffer A. Glu-Glu-SOS was eluted by applying buffer A
containing 50 mg/ml EYMPME peptide. SOS fractions were
pooled, concentrated, dialyzed against 50 mM Tris pH 7.5,
50 mM NaCl, 1 mM DTT and 50% glycerol, and stored at
220uC. Kept in this way, SOS retained nucleotide exchange
activity towards recombinant H-Ras for at least two weeks.
BrdU-based proliferation assay
NIH 3T3 cells expressing dox-inducible ezrin wild type or R40L
mutant were plated at low cell density on coverslips placed in 12-
well plates, followed by incubation with 20 mM/well bromodeox-
yuridin (BrdU, Oncogene) for 3 h. Cells were fixed with 4%
paraformaldehyde in ‘cytoskeleton buffer’ (CB: 10 mM PIPES,
150 mM NaCl, 5 mM EGTA, 5 mM glucose and 5 mM MgCl2,
pH 7.0) at room temperature (RT) for 20 min, washed three times
in PBS and permeated in 0.1% Triton-X-100 in PBS for 1 min.
After blocking in 1% BSA for 1 h, the coverslips were treated with
a cocktail of 2 mg/ml DAPI (Invitrogen), 250 mg/ml a-BrdU/
Fluorescein (Alexis), 106DNase-Buffer, DNase and 200 mg/ml a-
myc/TRITC for 1 h. Cells were washed three times in PBS,
mounted on glass slides with 10 ml Prolong Antifade reagent
(Molecular Probes) and images obtained using epifluorescence
with an Axiovert 135 TV microscope (Zeiss).
Soft agar assay
RT4 stably transfected cells were detached from culture plates
with 0.25% trypsin, resuspended in complete medium and
counted. Cells (1610
4) were resuspended in 3.6 ml of medium
containing 10% FCS. This mastermix was split into two,
doxycycline (1 mg/mL) was added to one half and to each mixture
200 ml of warm agar solution (stock is 3.3% in sterile PBS) was
added and mixed. The mixture was rapidly dispensed into 24-well
plates at 500 ml volume and cooled for 2 min at 4uC. Colonies
were counted after 10 to 14 days.
siRNA experiments
Single siRNA oligonucleotides were purchased from Ambion,
used siRNA sequences can be found in the Supplementary
methods. In brief 4610
5 cells were seeded overnight in a 10 cm
plate. Transfection of all siRNAs was performed using lipofecta-
mine according to manufacturer’s instructions. The following day
cells were given fresh medium and left to recover for at least 8 h.
Cells were serum starved overnight prior to 10 ng/ml PDGF
stimulation for 5 minutes.
siRNA with exogenous reconstitution of human ezrin,
radixin and moesin
NIH 3T3 cells were transfected with ERM siRNAs using
lipofectamine. The following day cells were given fresh medium
and left to recover for at least 8 h. Cells were then transfected with
plasmid DNA containing human ezrin, radixin and moesin using
lipofectamine according to manufacturer’s instructions. Cells were
serum starved overnight prior to 10 ng/ml PDGF stimulation for
5 min.
Affinity precipitation and immunoprecipitation
For pull-downs with GST-Raf1-RBD, cells were lysed in
25 mM HEPES pH 7.5, 150 mM NaCl, 10 mM MgCl2,1 %
Igepal CA-630, 10% glycerol, 1 mM EDTA, 1 mM sodium
vanadate, 1 mM PMSF, 10 mg/ml aprotinin and 10 mg/ml
leupeptin. For affinity precipitation supernatants were incubated
with 5 mg recombinant fusion protein rotating at 4uC for 1 h. Ras
assays were performed on pooled clones expressing ezrin wild type
compared to ezrin R579A mutant. 4610
5 cells were seeded
overnight in a 10 cm plate. Cells were serum starved overnight
prior to 10 ng/ml PDGF stimulation for 3 min. For pull-downs
with GST-Nterminal ezrin or GST-Grb2, cells were lysed in
25 mM HEPES pH 7.5, 20 mM NaCl, 10 mM MgCl2, 0.5%
Lubrol 17A17, 1 mM sodium vanadate, 1 mM PMSF, 10 mg/ml
aprotinin and 10 mg/ml leupeptin. Supernatants were incubated
with either 5 mg recombinant fusion protein rotating at 4uC
overnight. For all pull-downs 4610
5 cells were seeded overnight in
a 10 cm plate.
For immunoprecipitation procedure as in Morrison et al., 2001
[16]. In brief, 2610
6 cells were seeded overnight in a 20 cm plate.
Cells were serum starved overnight prior to 10 ng/ml PDGF
stimulation for 1 minute. Cells were lysed in 25 mM HEPES
pH 7.5, 20 mM NaCl, 0.5% Lubrol 17A17, 1 mM sodium
vanadate, 1 mM PMSF, 10 mg/ml aprotinin and 10 mg/ml
leupeptin. Supernatants were incubated with 2 mg of antibody
rotating at 4uC for 1 h.
SDS-PAGE, immunoblotting and coomassie staining
Following electrophoresis with 7.5–12.5% SDS-PAGE gels, the
proteins were transferred to PVDF membranes (Millipore) and
treated with blocking buffer (5% skimmed milk, 0.1% Tween-20,
10 mM Tris at pH 7.6 and 100 mM NaCl) at RT for 1 h. The
membranes were then incubated with primary antibody in
blocking buffer for another hour at RT or overnight at 4uC.
After three washes, the membranes were incubated with secondary
antibody at RT for 1 h, then developed and visualized using
enhanced chemiluminescence (Amersham). For coomassie-based
gel staining, Imperial protein stain solution (ThermoScientific) was
used. Immunoblotting quantification was performed using Quan-
tity One software (Bio-Rad Laboratories). Note: immunoblots for
aERM (unless otherwise stated) a mixture of ezrin (C-19), radixin
(C-15) and moesin (C-15) was used. For a single ezrin blot, the
3C12 antibody was used.
Pull-down assays using recombinant proteins
Ras/ezrin. Ras/ezrin interaction was tested for different
conditions (GTPcS-Ras vs. GDP-Ras) and different purified ezrin
protein mutants. Ras loading with nucleotides was performed as
described in Margarit et al., 2003 [43]. The respective His-tagged
ezrin protein (1–2 mg) was linked to Ni-Sepharose and incubated
with 50–100 ng loaded Ras in 500 ml interaction buffer (50 mM
HEPES pH 7.5, 50 mM NaCl, 10 mM MgCl2 and 0.5% Triton-
X-100) overnight at 4uC under constant rotation. The following
day, the probes were washed four times with 100 ml ice-cold
washing buffer (50 mM HEPES pH 7.5, 80 mM NaCl, 10 mM
MgCl2 and 0.5% Triton-X-100), with a short centrifugation step
between the washings. During the final washing step, the washing
buffer was completely removed and the remaining proteins were
subjected to SDS-PAGE and immunoblotting. SOS/ezrin: SOS/
ezrin interaction studies were performed either in the presence
or absence of F-actin/G-actin. G-actin (Cytoskeleton) was
polymerized to F-actin following the manufacturer’s protocol.
Interactions between SOS and ezrin, and F-actin/G-actin were
then carried out either in F-actin-Buffer (5 mM Tris pH 8.0,
0.2 mM CaCl2, 50 mM KCl, 2 mM MgCl2, 1.2 mM ATP and
0.5 mM DTT) or G-actin-Buffer (5 mM Tris pH 8.0, 0.2 mM
CaCl2, 0.2 mM ATP and 0.5 mM DTT) following the procedure
above.
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Nucleotide loading and nucleotide exchange measurements on
Ras were performed as described previously in Margarit et al.,
2003 [43]. Dissociation rates were measured on a fluorescence
spectrometer combined with a stop-flow device (SFM-400; Bio-
Logic). Substrate solution containing 1 mM mantGDP-Ras was
automatically mixed with reaction buffer supplemented with
200 mM GDP and additional proteins such as SOS and/or ezrin,
when indicated. Dissociation was measured for 360 s. The data
were fitted either to a linear (Y=I+B*x, with nucleotide
dissociation rate=absolute(B)), single exponential (Y=Y0+
A1
2k1*x) or bi-exponential (Y=Y0+A1
2k1*x+A2
2k2*x) function
(with I as the intercept, B as slope, A1/A2 as the amplitude, Y0
as the fluorescent value at infinite time, k1/k2 as the apparent
dissociation rate constant and x as time) using the program Origin
8Pro.
Supporting Information
Figure S1 ERM proteins are necessary for PDGFR
signaling. A, Loss of ERM binding to CD44 tail upon point
mutation of CD44. CD44 tail fused to GST was over-expressed in
RT4 cells kept at low cell density. Cells were lysed, GST-CD44 tail
was affinity-precipitated and derived complexes were analyzed by
Western blot employing a mixtureof antibodies against ERM
proteins and GST for loading. The mutated CD44 tail reveals
strongly diminished though not absent ERM binding. B–D,
Removal of the ERM proteins from the co-receptor at the plasma
membrane interfered with signalling. RT4 cells were transfected
with a construct expressing either the soluble ezrin-binding
domain of CD44 (GST-CD44tail) or the point-mutated domain
defective in ezrin binding (GST-CD44tail mutant). Transfected
cells were plated at low density,serum starved overnight prior to
induction with PDGF (10 ng/mL), lysed and immunoblotted as
indicated. B, PDGF induced stimulation (5 min) of Erk is
attenuated in cells expressing a soluble ERM binding domain
(wild type GST-CD44 tail) compared to a mutant version. C, D,
Kinetic resolution of PDGF induced signalling in cells expressing a
soluble ERM binding domain. PDGF induces a sharp incline in
Erk phosphorylation within 1 minute in cells expressing a mutant
form of the CD44 tail. Phosphorylation levels stay high in the
period investigated. Expression of the ERM binding domain (wild
type GST-CD44 tail) attenuates ERK activation characterized by
shifted phosphorylation maximum (from 1 to 5 minutes) and lower
fold-induction (from 19 to 5 times). Quantitation of pErk was
performed with ImageJ. E, F, Downregulation of ERM protein
expression reduces PDGF-dependent Erk phosphorylation. E,
RT4 cells were treated with two independent siRNA cocktails
against ERM proteins or control siRNA and serum starved
overnight prior to induction with PDGF (10 ng/ml, 5 min).
Lysates were immunoblotted as indicated. F, HeLa cells were
plated at low density, treated with a cocktail of siRNAs against all
three ERM proteins or control siRNA for 24 h, then serum
starved overnight prior to treatment with PDGF (10 ng/ml,
5 min). Lysates immunoblotted as indicated.
(TIF)
Figure S2 Ezrin R579A mutant inhibits PDGF-induced
Erk phosphorylation. A, RT4 cells expressing dox-inducible
ezrin wildtype-VSVg were plated at low density, serum starved
overnight prior to treatment with either PDGF (20 mM, 5 min),
TPA (100 ng/ml, 5 min) or IL-6 (1 ng/ml, 5 min). Lysates
immunoblotted as indicated. B, RT4 cells expressing dox-
inducible ezrin R579A mutant-VSVg were plated at low density,
serum starved overnight prior to treatment with either PDGF
(20 mM, 5 min), TPA (100 ng/ml, 5 min) or IL-6 (1 ng/ml,
5 min). Lysates immunoblotted as indicated.
(TIF)
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